drugbank_id,drug_score,drug_neg_log_score,trustrank,drug_name,drug_atc_code,drug_atc_label,uniprot_id,symbol,ensembl_id,drug|protein,interaction_label,actions
DB12010,6.024847282034262e-05,4.220053957119966,1,Fostamatinib,B02,Antihemorrhagics ,Q13547,HDAC1,ENSG00000116478,DB12010|Q13547,,
DB01268,5.261265829245396e-05,4.278909754606984,2,Sunitinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB01268|Q13547,,
DB09079,4.4915814704276894e-05,4.3476007184729175,3,Nintedanib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB09079|Q13547,,
DB06616,4.150284723531237e-05,4.381922108199509,4,Bosutinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB06616|Q13547,,
DB08865,3.2248828688863665e-05,4.491486054771384,5,Crizotinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB08865|Q13547,,
DB08877,2.704362808350753e-05,4.56793504531361,6,Ruxolitinib,D11,Other dermatological preparations ,Q13547,HDAC1,ENSG00000116478,DB08877|Q13547,,
DB08877,2.704362808350753e-05,4.56793504531361,6,Ruxolitinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB08877|Q13547,,
DB05294,2.544634917929209e-05,4.5943745176502695,7,Vandetanib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB05294|Q13547,,
DB06589,2.510462261200404e-05,4.600246302820049,8,Pazopanib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB06589|Q13547,,
DB11828,2.400713201104888e-05,4.619659719417025,9,Neratinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB11828|Q13547,,
DB06626,2.3455917613009592e-05,4.629747572460102,10,Axitinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB06626|Q13547,,
DB14487,2.1538595492993505e-05,4.666782619957721,11,Zinc Acetate,A16,Other alimentary tract and metabolism products ,Q13547,HDAC1,ENSG00000116478,DB14487|Q13547,,
DB01593,2.15385954929935e-05,4.666782619957721,11,,,,Q13547,HDAC1,ENSG00000116478,DB01593|Q13547,target_positiveEffect,cofactor
DB00317,1.8548626666220725e-05,4.731688239868956,13,Gefitinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB00317|Q13547,,
DB00619,1.84680670541574e-05,4.733578557274585,14,Imatinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB00619|Q13547,,
DB14533,1.761712517120152e-05,4.754064959950494,15,,,,Q13547,HDAC1,ENSG00000116478,DB14533|Q13547,target_positiveEffect,cofactor
DB14548,1.668917415607036e-05,4.777565153334853,16,,,,Q13547,HDAC1,ENSG00000116478,DB14548|Q13547,target_positiveEffect,cofactor
DB08916,1.2362544449116616e-05,4.907892133900619,17,Afatinib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB08916|Q13547,,
DB04315,9.189149872936772e-06,5.03672466517214,18,,,,Q13547,HDAC1,ENSG00000116478,DB04315|Q13547,,
DB13961,9.021356205757926e-06,5.044728168843611,19,,,,Q13547,HDAC1,ENSG00000116478,DB13961|Q13547,,
DB00313,7.730932646224004e-06,5.111768110392694,20,Valproic Acid,N03,Antiepileptics ,Q13547,HDAC1,ENSG00000116478,DB00313|Q13547,target_negativeEffect,inhibitor
DB00843,7.677537251290427e-06,5.114778067689762,21,Donepezil,N06,Psychoanaleptics ,Q13547,HDAC1,ENSG00000116478,DB00843|Q13547,,
DB06757,7.385224417146266e-06,5.131636303107965,22,,,,Q13547,HDAC1,ENSG00000116478,DB06757|Q13547,,
DB00852,7.305622285663001e-06,5.136342785380712,23,Pseudoephedrine,R01,Nasal preparations ,Q13547,HDAC1,ENSG00000116478,DB00852|Q13547,,
DB00795,7.019894559761724e-06,5.153669411012297,24,Sulfasalazine,A07,"Antidiarrheals, intestinal antiinflammatory/antiinfective agents ",Q13547,HDAC1,ENSG00000116478,DB00795|Q13547,,
DB00188,6.581159434323673e-06,5.181697587910189,25,Bortezomib,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB00188|Q13547,,
DB00162,6.266660444555067e-06,5.202963836662909,26,Retinol,R01,Nasal preparations ,Q13547,HDAC1,ENSG00000116478,DB00162|Q13547,,
DB00162,6.266660444555067e-06,5.202963836662909,26,Retinol,S01,Ophthalmologicals,Q13547,HDAC1,ENSG00000116478,DB00162|Q13547,,
DB00162,6.266660444555067e-06,5.202963836662909,26,Retinol,A11,Vitamins ,Q13547,HDAC1,ENSG00000116478,DB00162|Q13547,,
DB00162,6.266660444555067e-06,5.202963836662909,26,Retinol,D10,Anti-acne preparations ,Q13547,HDAC1,ENSG00000116478,DB00162|Q13547,,
DB04272,5.950701466672378e-06,5.225431836767462,27,Citric Acid,A09,"Digestives, incl. enzymes ",Q13547,HDAC1,ENSG00000116478,DB04272|Q13547,,
DB01411,5.403241820413637e-06,5.267345595310865,28,Pranlukast,R03,Drugs for obstructive airway diseases ,Q13547,HDAC1,ENSG00000116478,DB01411|Q13547,,
DB00755,5.384236329339959e-06,5.268875885954265,29,Tretinoin,D10,Anti-acne preparations ,Q13547,HDAC1,ENSG00000116478,DB00755|Q13547,,
DB00755,5.384236329339959e-06,5.268875885954265,29,Tretinoin,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB00755|Q13547,,
DB04464,5.210908849055661e-06,5.283086523589788,30,,,,Q13547,HDAC1,ENSG00000116478,DB04464|Q13547,,
DB13751,5.025413022855705e-06,5.298828239146109,31,Glycyrrhizin,A05,Bile and liver therapy ,Q13547,HDAC1,ENSG00000116478,DB13751|Q13547,,
DB12816,4.977192058911787e-06,5.303015600462273,32,,,,Q13547,HDAC1,ENSG00000116478,DB12816|Q13547,,
DB05767,4.717450662750079e-06,5.326292633188985,33,,,,Q13547,HDAC1,ENSG00000116478,DB05767|Q13547,,
DB08814,4.368269796236337e-06,5.359690546265269,34,Triflusal,B01,Antithrombotic agents ,Q13547,HDAC1,ENSG00000116478,DB08814|Q13547,,
DB14059,4.282389577072513e-06,5.368313826654655,35,,,,Q13547,HDAC1,ENSG00000116478,DB14059|Q13547,,
DB05487,4.242568114004518e-06,5.372371176400072,36,,,,Q13547,HDAC1,ENSG00000116478,DB05487|Q13547,,
DB14038,4.13319341373769e-06,5.383714271332469,37,,,,Q13547,HDAC1,ENSG00000116478,DB14038|Q13547,,
DB05464,4.084154020085369e-06,5.388897888325603,38,,,,Q13547,HDAC1,ENSG00000116478,DB05464|Q13547,,
DB05559,4.084154020085369e-06,5.388897888325603,38,,,,Q13547,HDAC1,ENSG00000116478,DB05559|Q13547,,
DB05451,4.084154020085369e-06,5.388897888325603,38,,,,Q13547,HDAC1,ENSG00000116478,DB05451|Q13547,,
DB05212,4.084154020085369e-06,5.388897888325603,38,,,,Q13547,HDAC1,ENSG00000116478,DB05212|Q13547,,
DB05471,4.084154020085369e-06,5.388897888325603,38,,,,Q13547,HDAC1,ENSG00000116478,DB05471|Q13547,,
DB02546,4.07058839824608e-06,5.390342809536034,43,Vorinostat,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB02546|Q13547,target_negativeEffect,inhibitor
DB01262,4.049631030363446e-06,5.392584544384561,44,Decitabine,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB01262|Q13547,target_negativeEffect,inhibitor
DB06176,3.994185821043323e-06,5.398571734363542,45,Romidepsin,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB06176|Q13547,target_negativeEffect,"antagonist, inhibitor"
DB06819,3.66980038118106e-06,5.435357558556998,46,,,,Q13547,HDAC1,ENSG00000116478,DB06819|Q13547,target_negativeEffect,inhibitor
DB01169,3.608271675371176e-06,5.442700770832786,47,,,,Q13547,HDAC1,ENSG00000116478,DB01169|Q13547,,
DB05289,3.5941264304453767e-06,5.444406649798272,48,,,,Q13547,HDAC1,ENSG00000116478,DB05289|Q13547,,
DB04998,3.5941264304453767e-06,5.444406649798272,48,,,,Q13547,HDAC1,ENSG00000116478,DB04998|Q13547,,
DB12847,3.508963300415411e-06,5.454821173964823,50,,,,Q13547,HDAC1,ENSG00000116478,DB12847|Q13547,target_negativeEffect,inhibitor
DB12645,3.508963300415411e-06,5.454821173964823,50,,,,Q13547,HDAC1,ENSG00000116478,DB12645|Q13547,target_negativeEffect,inhibitor
DB12565,3.508963300415411e-06,5.454821173964823,50,,,,Q13547,HDAC1,ENSG00000116478,DB12565|Q13547,target_negativeEffect,inhibitor
DB05015,3.508963300415411e-06,5.454821173964823,50,Belinostat,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB05015|Q13547,target_negativeEffect,inhibitor
DB06603,3.508963300415411e-06,5.454821173964823,50,Panobinostat,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB06603|Q13547,target_negativeEffect,inhibitor
DB11841,3.508963300415411e-06,5.454821173964823,50,Entinostat,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB11841|Q13547,target_negativeEffect,inhibitor
DB00227,3.5047835324661738e-06,5.455338800395926,56,Lovastatin,C10,Lipid modifying agents ,Q13547,HDAC1,ENSG00000116478,DB00227|Q13547,,
DB01076,2.7959048212710186e-06,5.553477617010891,57,Atorvastatin,C10,Lipid modifying agents ,Q13547,HDAC1,ENSG00000116478,DB01076|Q13547,,
DB00970,2.5991353840737256e-06,5.585171098327064,58,Dactinomycin,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB00970|Q13547,,
DB06334,2.5778578893582923e-06,5.588741027854864,59,,,,Q13547,HDAC1,ENSG00000116478,DB06334|Q13547,,
DB06769,2.568187937378688e-06,5.5903731982122205,60,Bendamustine,L01,Antineoplastic agents ,Q13547,HDAC1,ENSG00000116478,DB06769|Q13547,,
DB08868,2.4298777530566744e-06,5.614415575170576,61,,,,Q13547,HDAC1,ENSG00000116478,DB08868|Q13547,target_negativeEffect,inhibitor
DB05223,2.260686841021768e-06,5.645759593619086,62,,,,Q13547,HDAC1,ENSG00000116478,DB05223|Q13547,,
DB11830,2.1076986733071053e-06,5.676191477839964,63,,,,Q13547,HDAC1,ENSG00000116478,DB11830|Q13547,,
DB00061,1.940499620364189e-06,5.712086437888539,64,,,,Q13547,HDAC1,ENSG00000116478,DB00061|Q13547,,
DB03276,1.940499620364189e-06,5.712086437888539,64,,,,Q13547,HDAC1,ENSG00000116478,DB03276|Q13547,,
